Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCI-210 in Children With Autism Spectrum Disorder
NCT05182697Phase 2Recruiting
- Sponsor
- SciSparc
- Start
- Feb 2024
- Primary completion
- May 2026
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of SCI-210 in Autism Spectrum Disorder (ASD), sponsored by SciSparc. Started Feb 2024; status: recruiting.
02
Drugs
SCI-210
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05182697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05182697.